3i Group PLC
11 November 2005
UK Listing Authority Disclosure Rules
DR 3.1
As potential beneficiaries of The 3i Group Employee Trust (the 'Trust') all
employees of 3i Group plc (the 'Company') and its subsidiaries have an interest
in all the Ordinary Shares ('Shares') of 53 1/8p each in the Company held
by the Trust. These employees include the directors of 3i Group plc
('Directors') and persons discharging management responsibility ('PDMRs') in
respect of 3i Group plc for the purposes of the Disclosure Rules as follows:
Director and PDMR of 3i Group plc Philip Yea
Simon Ball
Michael Queen
PDMR of 3i Group plc Tony Brierley
Denise Collis
Jo Taylor
Chris Rowlands
Jonathan Russell
Paul Waller
On 10 November 2005, each of the Directors and PDMRs notified the Company that
on 10 November 2005 participants exercised options under the Company's
Management Equity Investment Plan ('MEIP') to acquire from the Trust 5,190
Shares at £nil per Share. The place of this transaction was the London Stock
Exchange.
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.